Craig Samuel

Craig Samuel possesses extensive experience in leadership roles across various innovative technology and healthcare companies. Currently serving on the Board of Directors at InfinitX, CENSIS, and Sofant Technologies, and holding advisory positions at Ava Innes and Movano Health, Craig is also the Chairman of the Board of Directors for XPRIZE and Neuro-Bio Ltd. Previously, Craig chaired Krucial and served as Chief Commercial Officer at JT IoT. With an academic background that includes a First Class BSc in Geology & Mineralogy from the University of Aberdeen and studies at Stanford University, Craig combines technical expertise with a commitment to leveraging technology for positive global impact.